Next Article in Journal
The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner
Next Article in Special Issue
In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection
Previous Article in Journal
Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays
Previous Article in Special Issue
Potential Drugs Targeting Early Innate Immune Evasion of SARS-Coronavirus 2 via 2’-O-Methylation of Viral RNA
Article

Article Versions Notes

Action Date Notes Link
article pdf uploaded. 10 June 2020 14:55 CEST Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/1999-4915/12/6/628/pdf
article pdf uploaded. 10 June 2020 14:55 CEST Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/1999-4915/12/6/628/pdf
article xml file uploaded 15 June 2020 11:13 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1999-4915/12/6/628/xml
article xml uploaded. 15 June 2020 11:13 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1999-4915/12/6/628/xml
article pdf uploaded. 15 June 2020 11:13 CEST Updated version of record https://0-www-mdpi-com.brum.beds.ac.uk/1999-4915/12/6/628/pdf
article html file updated 15 June 2020 11:15 CEST Update https://0-www-mdpi-com.brum.beds.ac.uk/1999-4915/12/6/628/html
Back to TopTop